Details of the Drug

General Information of Drug (ID: DML9Z8D)

• Drug Name: Autologous T-lymphocyte cell therapy
• Synonyms: Autologous T-lymphocyte cell therapy (G250-scFV-transduced, renal cell carcinoma)

Indication

Disease Entry	ICD 11	Status	REF
Peripheral vascular disease	BD4Z	Phase 2	[1]

• Cross-matching ID: TTD ID: D07TYM

References

• [1] Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Cancer J. 2012 Mar-Apr;18(2):160-75.